Abstract:You have accessJournal of UrologySexual Function/Dysfunction: Medical, Hormonal & Non-surgical Therapy II1 Apr 2017PD69-04 SAFETY AND EFFICACY OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION: A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED SHAM-CONTROLLED CLINICAL TRIAL Zhongcheng Xin, Ruili Guan, Wanshou Cui, Xiaodong Zhang, Long Tian, Yi Xie, Hongen Lei, Jihong Liu, and Tao Wang Zhongcheng XinZhongcheng Xin More articles by this author , Ruili GuanRuili Guan More articles by this author , Wanshou CuiWanshou Cui More articles by this author , Xiaodong ZhangXiaodong Zhang More articles by this author , Long TianLong Tian More articles by this author , Yi XieYi Xie More articles by this author , Hongen LeiHongen Lei More articles by this author , Jihong LiuJihong Liu More articles by this author , and Tao WangTao Wang More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.3145AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To evaluate the safety and efficacy of Low-intensity Extracorporeal Shockwave (LI-ESWT) in the Treatment of Vasculogenic Erectile Dysfunction. METHODS A multi-center, double-blind, randomized sham-controlled clinical trial was conducted. 70 patients (46 cases for LI-ESWT treatment group and 24 cases for the placebo group) at age 20-70 years, who had mild or moderate Vasculogenic ED evaluated with the International Index of Erectile Function erectile function domain (IIEF-EF) were recruited for this study. Screening, treatment and results were performed in sequence. 4 weekly sessions for the treatment stage: A total of 5000 shockwaves were applied for each treatment and 4 areas were conducted including: 900 shockwaves in right and left crura, and 1600 shockwaves in each site. Effectiveness was assessed according to the International Index of Erectile Function erectile function domain (IIEF-EF), questions 2 and 3 of the Sexual Encounter Profile (SEP), Global Assessment Question (GAQ) scores, and Erection Hardness Scale (EHS) at baseline and at 1 and 3 months after treatment. The study was approved by Peking University First Hospital ethics committee, and all patients signed an informed consent form. RESULTS For Full Analysis Set (FAS) and Per-Protocol Set (PPS), the average IIEF-EF increased significantly from 18.04±3.94 (17.90±3.77) at baseline to 22.02±4.13 (21.95±4.06) at 1 months post treatment, and was 22.54±3.98 (22.49±3.90) at the 3 months follow-up. The success rate by LI-ESWT is 67.39% (73.17%) after 1months post treatment VS 20.83% (23.81%) in the placebo group and is 69.57% (73.17%) after 3 months post treatment VS 20.83% (23.81%) in the placebo group by FAS (PPS). SEP, GAQ, EHS analysis were also significantly improved compared to the placebo controls (p<0.05). No side effects were reported in this study. CONCLUSIONS LI-ESWT in patients with mild or moderate Vasculogenic ED is a feasible, noninvasive and effective way for improving male ED. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e1345-e1346 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Zhongcheng Xin More articles by this author Ruili Guan More articles by this author Wanshou Cui More articles by this author Xiaodong Zhang More articles by this author Long Tian More articles by this author Yi Xie More articles by this author Hongen Lei More articles by this author Jihong Liu More articles by this author Tao Wang More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

PD69-04 SAFETY AND EFFICACY OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION: A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED SHAM-CONTROLLED CLINICAL TRIAL

(396) Low Intensity - Extracorporeal Shock Wave Therapy (Li-Eswt) In The Treatment Of Erectile Dysfunction: Initial Experience And Follow Up

(193) Low Intensity Shockwave Therapy in Combination with Phosphodiesterase-5 Inhibitors is an Effective and Safe Treatment Option in Patients with Vasculogenic ED who are PDE5i Nonresponders: A Multicenter Single-Arm Clinical Trial

Effectiveness of Low-Intensity Extracorporeal Shock Wave Therapy in Erectile Dysfunction: An Analysis of Sexual Function and Penile Hardness at Erection: An Umbrella Review

Retrospective analysis of the efficacy of low-intensity extracorporeal shock wave therapy on young and middle-aged patients with erectile dysfunction responsive to PDE5Is: reducing the use of PDE5Is

Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Myths and realities

Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial

Impact of low-intensity extracorporeal shockwave therapy on vascular parameters and sexual function in patients with arteriogenic erectile dysfunction

1028 EFFICACY AND POSSIBLE MECHANISM OF EXTRACORPOREAL SHOCK WAVE THERAPY ON STREPTOZOTOCIN INDUCED DIABETIC ERECTILE DYSFUNCTION RATS MODEL

(230) Investigating the Efficacy, Satisfaction, and Predictors of Response to Low-Intensity Shockwave Therapy for Erectile Dysfunction

(231) Low-Intensity Extracorporeal Shockwave Therapy Twice Per Week for Six Weeks May Result in Transient Subjective Improvements in Erectile Function

The Treatment Satisfaction in Patients and Their Partners Treated with Low-Intensity Extracorporeal Shock Wave Therapy and Sildenafil: A Prospective Non-Randomized Controlled Study

Efficacy and Safety of Novel Low-Intensity Pulsed Ultrasound (LIPUS) in Treating Mild to Moderate Erectile Dysfunction: a Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Study

(138) Efficacy and Patient Satisfaction of Low-Intensity Shockwave Treatment for Erectile Dysfunction in a Retrospective Real-World Study in Japan

(313) Low-Intensity Extracorporeal Shockwave Therapy May Result in Improvements in Flaccid Cavernosal Artery Peak Systolic Velocity

(281) Low-Intensity Shockwave Therapy Combined with Tadalafil 5mg Daily has Better Efficacy for Mild and Moderate Erectile Dysfunction: The Preliminary Results of a Multicenter Clinical Study in China

(181) Low Intensity Shockwave Therapy For Erectile Dysfunction: A Sham-Controlled Randomized Trial

The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial

Delayed Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates Impaired Penile Hemodynamics in Rats Subjected to Pelvic Neurovascular Injury.

Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?

(069) Markers of Neovascularization and Neurogenesis May Change After Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction